Even though Lockport is a very small school district (just 4,600 students overall), next fall when our students return to class they will be greeted with something no other schools in the nation have, a $2.7 million system of high-tech facial recognition cameras. The story behind those cameras is a cautionary tale of what can happen when your fears over school security let you be taken for a ride by clever salesmen.
REYKJAVÍK, ICELAND — Sometime in the future, U.S. researchers will be able to press a button and reliably identify the thousands of people who carry cancer-causing genes, including those that trigger breast cancer.
In Iceland, that day is already here. With a relatively uniform population and extensive DNA databases, Iceland could easily pinpoint which of its people are predisposed to certain diseases, and notify them immediately. So far, the government has refused to do so. Why? Iceland confronts legal and ethical obstacles that have divided the nation and foreshadow what larger countries may soon face.
“That is utter, thorough bulls–t,” Dr. Kári Stefánsson, a world-renowned Icelandic neurologist and biotech leader who has been at the center of the nation’s DNA debate, told McClatchy in an interview in his Reykjavík office. “There is a tradition in American society, there is a tradition in Icelandic society, to save people who are in life-threatening situations, without asking them for informed consent. Should there be a different rule if the danger is because of a mutated gene?”
The GDPR requires companies to send emails to people on their mailing list who have never bought anything, asking permission to keep emailing them.
Most Americans are not opening those emails, and some are using them to unsubscribe.
As a result, some email marketers stand to lose 80 percent of their marketing lists -- or face huge fines from the EU if they keep trying to email these people without permission.